A model of the temperature rise in the head due to magnetic resonance imaging procedures

1989 ◽  
Vol 9 (2) ◽  
pp. 177-184 ◽  
Author(s):  
T. Whit Athey
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Temperature Rise ◽  
Imaging Procedures ◽  
Resonance Imaging

Gadolinium In Medicine-An Evaluation and Update

2020 ◽  
pp. 1-7
Author(s):  
Blaurock-Busch Eleonore
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Chelating Agents ◽  
The Body ◽  
Imaging Procedures ◽  
Resonance Imaging ◽  
Intravenous Drugs ◽  
Gadolinium Retention ◽  
Magnetic Resonance Imaging Mri

Gadolinium-Based Contrast Agents (GBCA) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of Magnetic Resonance Imaging (MRI) or Magnetic Resonance Angiography (MRA). FDA alerts concerning potential side effects increased patient and medical concerns. More recent FDA information indicate that ionic gadolinium is released from some GBCAs, potentially causing gadolinium toxicity. We checked if gadolinium is excreted renally without intervention after previous administration of GBCAs, and if chelating agents are effective in removing gadolinium that may have remained in the body after GBCA administration. Through the evaluation of our internal database and the studies of others, we concluded that no clear consensus exists at this time. While the DTPAs may be the choice of chelators for the removal of gadolinium from the human body, further studies are needed to prove this. It seems clear, however, that microcyclic GBCAs provide a lesser risk of causing gadolinium retention and gadolinium toxicity symptoms.

Sign in / Sign up

Export Citation Format

Share Document